definiens: means ( i ) the Targets listed on Exhibit A hereto and(ii ), in addition to those Targets covered under ( i ), any other Target ( other than a Five Prime Reserved Target)with respect to which ( a ) [COMPANY] has filed an IND with respect to an agent that modulates such Target, ( b ) [COMPANY] isusing commercially reasonable efforts to develop such agent, ( c ) the development of such agent in combinationwith a Licensed Antibody or Licensed Product is included in the Development Plan and ( d ) [COMPANY] has a bona fideintent to initiate a * * * Clinical Trial of such agent in combination with a Licensed Antibody or Licensed Productwithin * * * with respect to such agent ( such agent, a ), provided, however, anyTarget identified in ( ii ) would remain a [COMPANY] Reserved Pipeline Target only if [COMPANY] initiates * * * INDICATES MATERIAL THAT WAS OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT WAS REQUESTED . ALL SUCHOMITTED MATERIAL WAS FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE24b-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED